These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

963 related items for PubMed ID: 20347267

  • 1. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L, Jaffe A, Levine J.
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.
    Covell NH, McEvoy JP, Schooler NR, Stroup TS, Jackson CT, Rojas IA, Essock SM, Schizophrenia Trials Network.
    J Clin Psychiatry; 2012 May; 73(5):669-75. PubMed ID: 22480442
    [Abstract] [Full Text] [Related]

  • 3. Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
    Turner M, Eerdekens E, Jacko M, Eerdekens M.
    Int Clin Psychopharmacol; 2004 Jul; 19(4):241-9. PubMed ID: 15201572
    [Abstract] [Full Text] [Related]

  • 4. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of inpatient depot antipsychotic prescribing.
    Pabis DJ, Dorson PG, Crismon ML.
    Ann Pharmacother; 1996 Dec; 30(12):1381-6. PubMed ID: 8968447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dose response of prophylactic antipsychotics.
    Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M.
    J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
    [Abstract] [Full Text] [Related]

  • 15. Rehospitalization risk with second-generation and depot antipsychotics.
    Conley RR, Kelly DL, Love RC, McMahon RP.
    Ann Clin Psychiatry; 2003 Mar; 15(1):23-31. PubMed ID: 12839430
    [Abstract] [Full Text] [Related]

  • 16. Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.
    Olfson M, Marcus SC, Ascher-Svanum H.
    Schizophr Bull; 2007 Nov; 33(6):1379-87. PubMed ID: 17470444
    [Abstract] [Full Text] [Related]

  • 17. Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.
    Leatherman SM, Liang MH, Krystal JH, Lew RA, Valley D, Thwin SS, Rosenheck RA, CSP 555 Investigators.
    J Nerv Ment Dis; 2014 Jan; 202(1):13-7. PubMed ID: 24375206
    [Abstract] [Full Text] [Related]

  • 18. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z, Britvić D, Vuković O, Ille T.
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [Abstract] [Full Text] [Related]

  • 19. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
    Uchida T, Suzuki T, Sakurai H, Tsutsumi C, Den R, Mimura M, Uchida H.
    Int Clin Psychopharmacol; 2013 Sep; 28(5):261-6. PubMed ID: 23820334
    [Abstract] [Full Text] [Related]

  • 20. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
    Taylor DM, Young CL, Mace S, Patel MX.
    J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.